FOR PROVIDERS

CancerVision

Gain comprehensive insights into your
patients’ cancer with our whole genome approach

See your patients' cancer from every angle with our whole genome approach

CancerVision provides timely actionable insights derived from comprehensive genomic data, enabling you to make informed decisions tailored to each patient's unique biology.

*Note: Read outs below from the same subject

Targeted Panel

<0.1%

Genome-wide coverage: <0.1%

Point mutations identified (n=6)

No copy number variations

No structural variations

Whole Exome

1-2%

Genome-wide coverage: 1-2%

Point mutations identified (n=74)

Inaccurate copy number variations

No structural variations

Whole Genome

>90%

Genome-wide coverage: >90%

Point mutations identified (n=6,003)

Copy number variations fully covered

Structural variations fully covered

Providing clarity in the face of complexity

Whole genome sequencing provides a more complete view (>90%) of your patient’s genetic makeup than other tests.
We sequence patient-matched tumor and normal samples to highly refined insights to inform treatment decisions.

Minimizes false positives by identifying and ruling out benign variants in the tumor sample

Reduces overestimation of tumor mutational burden (TMB) calculations by excluding mutations found in both the tumor and normal samples.

The CancerVision Report

Our report prioritizes the most relevant and actionable insights, enabling timely
decision-making:

Genetic variations and fusions linked to FDA-approved treatments*

Additional genomic findings including TMB, MSI, and copy number, associated with personalized treatment approaches.

Clinical trial opportunities to assist with future steps

Easy access to deeper data to enhance your decision-making process without any unnecessary hurdles

*The Cancer Vision test is not an FDA-cleared or -approved IVD device or companion diagnostic for the referenced biomarkers and FDA-approved therapies.

Explore the Report

How to order a test

Place your order

Please download and fill out our Test Requisition Form. This form can be faxed or emailed to the appropriate Genome Insight facility.

Inquiries: inquiry@ genomeinsight.net

CancerVision specimen kit

Cancer Vision requires two samples (solid tumor tissue and matched-normal blood), which often ship from different locations.
Genome Insight will work directly with the pathology team and the treating physician to obtain samples of both solid tumor tissue and matched-normal blood samples.

Ship sample

Ship samples in the supplied CancerVision specimen kits.

Access test results

Most Cancer Vision reports are available within 14 days from the date we receive both the tumor sample and the matched normal blood sample in our laboratory. You can access the results through the online provider portal or receive the report by fax.

Test Name	Tumor Requirements	Paired Normal Requirements	TAT	Location Offered
CancerVision	1-10 FFPE from curls or slides, with H&E stained slide for reference	2-4mL peripheral blood, or previously extracted DNA from a CLIA certified laboratory	10-14 days	Global

Frequently Asked Questions

How do I order a Genome Insight test?

To order a test please download and complete the test requisition form and email it to: inquiry@genomeinisght.com

What are the sample type requirements?

The test requires both a tumor sample and normal blood sample. For tumor (FFPE) samples, the sample requirements are 10 unstained slides from a single tumor, totaling over 50 microns, along with a H&E stained slide for reference. Alternatively, DNA extracted by a CLIA-certified laboratory is accepted, with a minimum concentration of 200ng/uL and a minimum of 1ug. Matched normal samples require a minimum of 3mL EDTA and must not be clotted or hemolyzed. Samples must be received within 7 days of collection, and it should be noted that the CancerVision Test generally takes 50-100 microns of tissue and the submitted tissue may be exhausted to perform the requested testing.

How do I obtain the results of a Genome Insight test?

Genome Insight test reports can be accessed as soon as results are ready via our digital reporting portal. You can also receive access to results via secure email or request to have results faxed to you.

Don’t see your question?